Previous close | 54.32 |
Open | 54.79 |
Bid | 54.21 x 100 |
Ask | 54.51 x 200 |
Day's range | 53.70 - 55.62 |
52-week range | 19.81 - 61.61 |
Volume | |
Avg. volume | 1,048,309 |
Market cap | 3.651B |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Merus' stock price is sensitive to their trading...
The latest analyst coverage could presage a bad day for Merus N.V. ( NASDAQ:MRUS ), with the analysts making...
Data from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy achieved a 60% response rate in patients with head and neck cancer.